These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15686898)

  • 1. Molecular docking of the highly hypolipidemic agent alpha-asarone with the catalytic portion of HMG-CoA reductase.
    Medina-Franco JL; López-Vallejo F; Rodríguez-Morales S; Castillo R; Chamorro G; Tamariz J
    Bioorg Med Chem Lett; 2005 Feb; 15(4):989-94. PubMed ID: 15686898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and docking of highly hypolipidemic agents: Schizosaccharomyces pombe as a new model for evaluating alpha-asarone-based HMG-CoA reductase inhibitors.
    Argüelles N; Sánchez-Sandoval E; Mendieta A; Villa-Tanaca L; Garduño-Siciliano L; Jiménez F; Cruz Mdel C; Medina-Franco JL; Chamorro-Cevallos G; Tamariz J
    Bioorg Med Chem; 2010 Jun; 18(12):4238-48. PubMed ID: 20576575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and highly potent hypolipidemic activity of alpha-asarone- and fibrate-based 2-acyl and 2-alkyl phenols as HMG-CoA reductase inhibitors.
    Mendieta A; Jiménez F; Garduño-Siciliano L; Mojica-Villegas A; Rosales-Acosta B; Villa-Tanaca L; Chamorro-Cevallos G; Medina-Franco JL; Meurice N; Gutiérrez RU; Montiel LE; Cruz Mdel C; Tamariz J
    Bioorg Med Chem; 2014 Nov; 22(21):5871-82. PubMed ID: 25311563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of HMG-CoA Reductase: Current and Future Prospects.
    Singh N; Tamariz J; Chamorro G; Medina-Franco JL
    Mini Rev Med Chem; 2009 Oct; 9(11):1272-83. PubMed ID: 19929805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural mechanism for statin inhibition of HMG-CoA reductase.
    Istvan ES; Deisenhofer J
    Science; 2001 May; 292(5519):1160-4. PubMed ID: 11349148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into the mechanism of polyphenols on the activity of HMGR by molecular docking.
    Islam B; Sharma C; Adem A; Aburawi E; Ojha S
    Drug Des Devel Ther; 2015; 9():4943-51. PubMed ID: 26357462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure of the catalytic portion of human HMG-CoA reductase.
    Istvan ES; Deisenhofer J
    Biochim Biophys Acta; 2000 Dec; 1529(1-3):9-18. PubMed ID: 11111074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Inhibitors of HMG-CoA Reductase-An Insilico Approach Through Molecular Docking and Simulation Studies.
    Suganya S; Nandagopal B; Anbarasu A
    J Cell Biochem; 2017 Jan; 118(1):52-57. PubMed ID: 27216569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia.
    da Silva VB; Taft CA; Silva CH
    J Phys Chem A; 2008 Mar; 112(10):2007-11. PubMed ID: 18044855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteopedia entry: HMG-CoA reductase.
    Canner D
    Biochem Mol Biol Educ; 2011; 39(1):64. PubMed ID: 21433257
    [No Abstract]   [Full Text] [Related]  

  • 11. Exploration of natural product ingredients as inhibitors of human HMG-CoA reductase through structure-based virtual screening.
    Lin SH; Huang KJ; Weng CF; Shiuan D
    Drug Des Devel Ther; 2015; 9():3313-24. PubMed ID: 26170618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of new druggable sites in the anti-cholesterol target HMG-CoA reductase by computational alanine scanning mutagenesis.
    Gesto DS; Cerqueira NM; Ramos MJ; Fernandes PA
    J Mol Model; 2014 Apr; 20(4):2178. PubMed ID: 24671303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding effect and design of a competitive inhibitory peptide for HMG-CoA reductase through modeling of an active peptide backbone.
    Pak VV; Koo M; Kim MJ; Yun L; Kwon DY
    Bioorg Med Chem; 2008 Feb; 16(3):1309-18. PubMed ID: 17977732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis.
    Istvan ES; Palnitkar M; Buchanan SK; Deisenhofer J
    EMBO J; 2000 Mar; 19(5):819-30. PubMed ID: 10698924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based rational quest for potential novel inhibitors of human HMG-CoA reductase by combining CoMFA 3D QSAR modeling and virtual screening.
    Zhang QY; Wan J; Xu X; Yang GF; Ren YL; Liu JJ; Wang H; Guo Y
    J Comb Chem; 2007; 9(1):131-8. PubMed ID: 17206841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of virtual candidates for human HMG-CoA reductase inhibitors using pharmacophore modeling and molecular dynamics simulations.
    Son M; Baek A; Sakkiah S; Park C; John S; Lee KW
    PLoS One; 2013; 8(12):e83496. PubMed ID: 24386216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in silico studies of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitory activity of the cowpea Gln-Asp-Phe peptide.
    Silva MBCE; Souza CADC; Philadelpho BO; Cunha MMND; Batista FPR; Silva JRD; Druzian JI; Castilho MS; Cilli EM; Ferreira ES
    Food Chem; 2018 Sep; 259():270-277. PubMed ID: 29680054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,4,5-trimethoxycinnamic acid: the major metabolite of alpha-asarone, retains most of the pharmacological properties of alpha-asarone.
    Antunez-Solis J; Hernández-Derramadero F; Aquino-Vega M; Ibarra-Ramírez S; Rodríguez-Páez L; Baeza I; Wong C
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):903-9. PubMed ID: 18686138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IAF, QGF, and QDF Peptides Exhibit Cholesterol-Lowering Activity through a Statin-like HMG-CoA Reductase Regulation Mechanism: In Silico and In Vitro Approach.
    Silva M; Philadelpho B; Santos J; Souza V; Souza C; Santiago V; Silva J; Souza C; Azeredo F; Castilho M; Cilli E; Ferreira E
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a new class of HMG-CoA reductase inhibitor from Polyalthia longifolia as potential lipid lowering agent.
    Sashidhara KV; Singh SP; Srivastava A; Puri A; Chhonker YS; Bhatta RS; Shah P; Siddiqi MI
    Eur J Med Chem; 2011 Oct; 46(10):5206-11. PubMed ID: 21872367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.